Canopy Growth (NASDAQ:CGC) Shares Up 15.4% – Here’s What Happened

Shares of Canopy Growth Corporation (NASDAQ:CGC) shot up 15.4% on Wednesday . The company traded as high as $1.47 and last traded at $1.3150. 16,154,095 shares changed hands during trading, an increase of 50% from the average session volume of 10,778,372 shares. The stock had previously closed at $1.14.

Key Canopy Growth News

Here are the key news stories impacting Canopy Growth this week:

• Positive Sentiment: U.S. rescheduling momentum: reports say the administration has moved to reclassify marijuana to a less-dangerous category and opened an expedited hearing process, a major regulatory tailwind for cannabis companies if formalized. Article Title
• Positive Sentiment: Sector spillover: peers such as Tilray jumped sharply on rescheduling speculation, showing the market’s willingness to re-rate cannabis names if regulatory progress continues — a potential catalyst for CGC upside. Article Title
• Positive Sentiment: Investor optimism reflected in commentary: Canopy rallied earlier on renewed hope around rescheduling, reinforcing that regulatory developments—not near-term fundamentals—are currently the largest directional driver. Article Title
• Neutral Sentiment: Company marketing update: Canopy rolled out a Tweed brand refresh and national summer campaign that may support Canadian retail sales but is unlikely to move the stock materially near-term. Article Title
• Neutral Sentiment: Unusual options activity: traders detected large/options volume in CGC, which can amplify intraday moves and volatility but does not by itself confirm a directional fundamental shift. Article Title
• Neutral Sentiment: Market volatility: coverage notes cannabis names “soared then sank” as traders reacted to headlines then reversed positions — underscores event-driven swings for CGC. Article Title
• Negative Sentiment: Investor caution remains: analysts and commentary warn pot stocks are still risky despite rescheduling talk, highlighting weak fundamentals, past earnings misses and potential execution risks for multi-jurisdiction operators like Canopy. Article Title
• Negative Sentiment: Short-term profit-taking and headline-driven selling: coverage asking “what’s going on” with CGC notes that earlier gains have been trimmed as traders lock in profits and reassess odds of quick regulatory change. Article Title

Wall Street Analyst Weigh In

CGC has been the subject of several research analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Canopy Growth in a research note on Monday. Alliance Global Partners reaffirmed a “neutral” rating on shares of Canopy Growth in a research note on Saturday, February 7th. Wall Street Zen lowered shares of Canopy Growth from a “hold” rating to a “sell” rating in a research report on Sunday, March 29th. ATB Cormark Capital Markets upgraded shares of Canopy Growth from a “strong sell” rating to a “moderate buy” rating in a report on Tuesday, March 17th. Finally, Canaccord Genuity Group started coverage on shares of Canopy Growth in a research report on Friday, March 27th. They set a “buy” rating on the stock. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold”.

Canopy Growth Trading Down 2.9%

The firm has a market capitalization of $478.88 million, a PE ratio of -0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.30, a current ratio of 5.34 and a quick ratio of 4.26. The company has a fifty day moving average of $1.07 and a 200-day moving average of $1.18.

Canopy Growth (NASDAQ:CGC) last issued its earnings results on Friday, February 6th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Canopy Growth had a negative net margin of 94.39% and a negative return on equity of 46.85%. The firm had revenue of $90.39 million during the quarter, compared to analysts’ expectations of $70.96 million. On average, sell-side analysts anticipate that Canopy Growth Corporation will post -0.36 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Canopy Growth

A number of hedge funds have recently added to or reduced their stakes in CGC. Midwest Trust Co acquired a new stake in Canopy Growth in the third quarter valued at approximately $31,000. Boothbay Fund Management LLC bought a new position in shares of Canopy Growth during the 2nd quarter valued at $30,000. Bank of Montreal Can raised its holdings in shares of Canopy Growth by 122.7% during the 4th quarter. Bank of Montreal Can now owns 25,174 shares of the company’s stock valued at $29,000 after purchasing an additional 135,970 shares in the last quarter. Octavia Wealth Advisors LLC acquired a new stake in shares of Canopy Growth in the 4th quarter valued at $30,000. Finally, PCG Wealth Advisors LLC acquired a new stake in shares of Canopy Growth in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 3.33% of the company’s stock.

Canopy Growth Company Profile

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.